Boston, MA, United States of America

Ryan Quiroz


 

Average Co-Inventor Count = 10.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Journey of Inventor Ryan Quiroz

Introduction

Ryan Quiroz, based in Boston, MA, is a notable inventor with a portfolio of four patents. His work predominantly focuses on advancements in medical science, specifically in the treatment of various diseases. Quiroz's innovative contributions highlight the crucial intersection of research and practical application in the field of pharmaceuticals.

Latest Patents

Among his latest patents are a series of PRMT5 inhibitors, which include compounds of Formula (I) and their pharmaceutically acceptable salts, esters, and prodrugs. These inhibitors are designed to target PRMT5, a critical enzyme linked to several health conditions. The inventions not only outline the compounds but also detail methods of producing these substances, pharmaceutical compositions containing them, and their applications in treating cancer, sickle cell disease, and hereditary persistence of fetal hemoglobin (HPFH) mutations.

Career Highlights

Throughout his career, Ryan Quiroz has been associated with prestigious institutions such as Leland Stanford Junior University and Merck Sharp & Dohme Corporation. His work in these organizations has laid a strong foundation for his innovative endeavors, allowing him to make significant contributions to medical research and drug development.

Collaborations

Ryan has collaborated with esteemed colleagues including Paul A. Wender and Stephen Ho. These partnerships have fostered a dynamic exchange of ideas, contributing to the advancement of their collective research goals. Such collaborations underscore the importance of teamwork in the pursuit of groundbreaking medical innovations.

Conclusion

Ryan Quiroz stands out as a dedicated inventor committed to advancing healthcare through his innovative patents. His contributions to PRMT5 inhibitors represent a beacon of hope for patients suffering from serious medical conditions. With his experience and collaborative spirit, Quiroz is poised to continue making impactful strides in the field of pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…